Skip to main content

LENSAR, Inc. (LNSR)

NASDAQ: LNSR · Delayed Price · USD
8.08 -0.05 (-0.62%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap87.43M
Revenue (ttm)30.39M
Net Income (ttm)-21.14M
Shares Out10.96M
EPS (ttm)-2.43
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,778
Open8.03
Previous Close8.13
Day's Range7.84 - 8.08
52-Week Range3.16 - 12.71
Betan/a
Analystsn/a
Price Target20.00 (+147.5%)
Est. Earnings DateNov 4, 2021

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

IndustryMedical Devices
Employees100
Stock ExchangeNASDAQ
Ticker SymbolLNSR
Full Company Profile

Financial Performance

In 2020, LENSAR, Inc's revenue was $26.38 million, a decrease of -13.58% compared to the previous year's $30.53 million. Losses were -$19.77 million, 34.9% more than in 2019.

Financial Statements

News

LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

3 weeks ago - Business Wire

LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

1 month ago - Business Wire

LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

1 month ago - Business Wire

LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

1 month ago - Business Wire

LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the ...

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

2 months ago - Business Wire

LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

4 months ago - Business Wire

LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

4 months ago - Business Wire

LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

4 months ago - Business Wire

LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

6 months ago - Business Wire

LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, ...

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

6 months ago - Business Wire

LENSAR to Present at Two Upcoming Investor Conferences

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of...

7 months ago - Business Wire

LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G.

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq:LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts...

7 months ago - Business Wire